Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis |
| |
Authors: | Jae Han Lee,So Hee Han,You Min Kim,Sung Hyun Kim,Eun Seon Yoo,Joong Seok Woo,Gi Hwan Jung,Soo Hyun Jung,Bum Seok Kim,Ji Youn Jung |
| |
Affiliation: | 1.Department of Companion and Laboratory Animal Science, Kongju National University, Yesan, Republic of Korea;2.College of Veterinary Medicine and Bio-safety Research Institute, Jeonbuk National University, Iksan, Republic of Korea |
| |
Abstract: | Shikonin, a natural product isolated from the roots of Lithospermum erythrorhizon, exhibits pharmacological effects against inflammation, ulcers, infections, and tumors. In the present study, we aimed to investigate the antitumor effects of shikonin on the human melanoma cell line, A375SM, and in an in vivo mouse xenograft model. We examined the anticancer effects of shikonin by in vitro experiments (MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, 4′,6-diamidino-2-phenylindole (DAPI) stain, annexin V/ propidium iodide (PI) stain, and protein analysis of apoptosis and mitogen-activated protein kinase (MAPK) pathways). Further, the anticancer effect in vivo was confirmed through a xenograft model. Our results showed that shikonin inhibited the proliferation of melanoma cells in a dose-dependent manner. In addition, shikonin significantly increased nucleus and chromatin condensation and early/late apoptosis. Shikonin also increased the pro-apoptotic proteins and decreased the anti-apoptotic proteins. Additionally, shikonin was overexpressed in MAPK pathways. Investigation of the effects of shikonin in a mouse xenograft model not only showed decreased A375SM tumor volume but also increased apoptosis as determined by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Furthermore, pathologic changes were not observed in the liver and kidney of mice. Collectively, the study indicated that shikonin inhibited the proliferation of the human melanoma cells by inducing apoptosis, mediated by MAPK pathway and that it is a potential candidate for an anticancer drug against melanoma cancer. |
| |
Keywords: | apoptosis Melanoma cells mitogen-activated protein kinases Shikonin |
|
|